Newsletters


 

The Regulation Digest

 

A weekly compendium of regulatory policy, news, and analysis.

 

SUBSCRIBE TODAY!


This week's edition...

 

 

January 19, 2022 -- Volume 11, Number 3

Features rulemaking activity related to COVID-19 by FEMA and OCC. Plus other notable actions by DOE, ITC, FDA, and Treasury.

With opinions and analysis from Zhoudan Xie, Mark Febrizio, Susan Dudley, Eugene Volokh, Jonathan Adler, Eugene Scalia, Linda Greenhouse, Wayne Crews, Paul Kupiec, Jennifer Schulp, Binyamin Appelbaum, Christopher Walker, Andrew Rudalevige, Richard Morrison, Jeffrey Singer, Ilya Shapiro, Sandra Zellmer, Randy May, Hodan Omaar, Daniel Castro, Salim Furth, Kairon Shayne Garcia, Michael Mandel, Brian Prest, Henry Miller, Juan Londoño, and others.

Plus news from New York TimesAssociated PressWall Street JournalThe HillE&E News, and Bloomberg.



Photo of Roslyn Layton

Dr. Roslyn Layton

Visiting Scholar
American Enterprise Institute

"The Regulation Digest is better than an algorithm."



Photo of Adam White.

Adam J. White

Executive Director
Center for the Study of the Administrative State

"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."


Previous editions

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, FEMA, and HHS. Plus other notable actions by ACUS, CPSC, NTIA, OPM, and CMS.

With opinions and analysis from Susan Dudley, Bridget Dooling, Laura Stanley, Cary Coglianese, David Michaels, Sarah Walker McRae, David Rivkin, Luc Montagnier, Ilya Shapiro, Wendy Parmet, Vivek Ramaswamy, Ruth Marcus, Jonathan Adler, Ramesh Ponnuru, Todd Graziano, Robert Powelson, Shane Tews, David Dayen, Daniel Farber, Sarah Ladin, Kofi Ampaabeng, Aurelien Portuese, and others.

Plus news from New York TimesAssociated PressWall Street JournalThe HillReutersWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by President Biden, ED, PTO, HHS, HRSA, CBP, DOL, and Treasury. Plus other notable actions by NHTSA, EPA, and DHS.

With opinions and analysis from Kristin Hickman, Bridget Dooling, Dylan Desjardins, Jonathan Lesser, Peter Wallison, Greg Ip, Kristian Stout, Hugh Helferty, Roslyn Layton, Thomas Miller, Todd Zywicki, Mario Lopez, Ilya Somin, Aurelien Portuese, Anne Joseph O'Connell, Dan Bosch, Jack Lienke, Chelsea Boyd, and Damonta Morgan.

Plus news from New York TimesWall Street JournalThe HillReutersWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by CDC, CFA, NCUA, and FNS. Plus other notable actions by EPA, DHS, and DOE.

With opinions and analysis from Mark Febrizio, Anya Bernstein, Elizabeth Slattery, Phil Gramm, Joshua Wright, Jay Clayton, James Broughel, Roslyn Layton, Randy May, Diana Furchtgott-Roth, Henry Miller, Jonathan Adler, Wayne Crews, Clark Nardinelli, Casey Mulligan, Dan Bosch, Devin Watkins, Daniel Castro, Katelynn Catalano, and others.

Plus news from NPRNew York TimesWall Street JournalThe HillAssociated PressWashington PostAxios, Reuters, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the FTZ Board and the Dept. of State. Plus other notable actions by OIRA, DOE, FTC, and DHS.

With opinions and analysis from Daniel Perez, James Freeman, Mehrsa Baradaran, Paul Sabin, Wayne Crews, Jonathan Adler, Stuart Shapiro, Matt Levine, Kara Swisher, Bilal Sayyed, Cary Coglianese, Randolph May, Richard Pierce, Soojin Jeong, Isabel Soto, Richard Morrison, Sarah Ladin, Liza Reed, Elise Amez-Droz, Wayne Winegarden, and James Broughel.

Plus news from New York TimesWall Street JournalThe HillAssociated PressWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by HHS, HRSA, FEMA, OSHA, and Treasury. Plus other notable actions by EPA, CFPB, GSA, FDA, and FHWA.

With opinions and analysis from Susan Dudley, Richard Pierce, Richard Epstein, Adam Thierer, David Michaels, Jonathan Adler, Michelle Leder, Roslyn Layton, Bridget Pals, Mary Anastasia O'Grady, Naomi Lopez, Josia Neeley, Sofia Ranchordas, J.W. Verrett, Ewelina Czapla, Daniel Lyons, Brian Knight, Bryan Caplan, Nicholas Bagley, and others.

Plus news from E&E NewsThe HillNew York TimesWall Street JournalAssociated Press, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the OSHA, EOP, and CFA. Plus other notable actions by DOL, FHWA, ETA, FWS, and NOAA.

With opinions and analysis from Mark Febrizio, Sarah Binder, Mark Spindel, Samuel Hammond, Daniel Takash, Steven Teles, Trey Malone, Aaron Staples, Roslyn Layton, Cynthina Lummis, James Pethokoukis, Oonagh McDonald, Peter Walliscon, Howard Husock, John Cochrane, and Benjamin Zycher.

Plus news from New York TimesWall Street JournalThe HillAssociated PressWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by the EOP, OMB, HHS, SBA, and VA. Plus other notable actions by EPA, DEA, State, PHMS, DOL, and CMS.

With opinions and analysis from Zhoudan Xie, Susan Dudley, Sally Katzen, Jonathan Adler, Ruth Marcus, Ilya Shapiro, William Yeatman, Susan Webb Yackee, Shoshana Zuboff, Lindsay Mark Lewis, Joseph Aldy, Jenny Schuetz, Randy May, Henry Miller, Jack Lienke, Brent Skorup, Robert Graboyes, and Brian Knight.

Plus news from NPRNew York TimesWall Street JournalThe HillAssociated PressWashington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by OSHA, CMS, and CDC. Plus other notable actions by EPA, ACE, CFPB, ED, and FMCSA.

With opinions and analysis from Daniel Pérez, Richard Pierce, Todd Zywicki, Jonathan Adler, Miranda Yaver, Jonathan Turley, Stephen Mihm, Jack Lienke, Allysia Finley, Michael Cannon, Farhad Manjoo, Roslyn Layton, Henry Miller,  Courtney Joslin, John Yoo, Christopher Walker, Arielle Kane, and James Broughel.

Plus news from E&E News, New York Times, Wall Street Journal, The Hill, Associated Press, Washington Post, and Bloomberg.

FULL NEWSLETTER

Features rulemaking activity related to COVID-19 by EOP, CDC, FDA, and FEMA. Plus other notable actions by NOAA, FAA, DOL, FEMA, HHS, and ED.

With opinions and analysis from Laura Stanley, Bridget Dooling, James Capretta, Kimberley Strassel, Tyler Cowen, Matt Levine, Roslyn Layton, Benjamin Zycher, Jonathan Adler, Daniel Takash, Yeong Jae Kim, Brian Frye, Cary Coglianese, Dan Bosch, Jefrey Singer, Angela Logomasini, Tori Smith, and Richard Revesz.

Plus news from E&E NewsNew York TimesWall Street JournalThe HillAssociated PressWashington Post, and Bloomberg.

 

 


 

The Regulatory Studies Center Update

 

A monthly(ish) collection of working papers, events, op-eds, and insights.

 

SUBSCRIBE TODAY!

Most recent edition...

Screenshot of the GW Regulatory Studies Center's update on November 16, 2021.

 

NOVEMBER 2021

This update features a Minnesota Law Review Article by Bridget Dooling and Laura Stanley: Extending Pandemic Flexibilities for Opioid Use Disorder Treatment.

As former administrators of the Office of Information and Regulatory Affairs for bipartisan administrations, Susan Dudley co-authored an op-ed with Sally Katzen for RealClear Policy, Senators Working Across the Aisle for Better Regulation, to discuss current reforms introduced by Senators Kyrsten Sinema (D-AZ) and James Lankford (R-AZ).

There is also insights by Zhoudan Xie on regulatory uncertainty, Daniel Pérez on a recent draft ACUS report to improve the Congressional Review Act, Bridget Dooling on the Benefits of Rowdy Bureacracy and the OSHA vaccine mandate, and Laura Stanley on interim-final rules.  Plus commentaries by our graduate students Timberley Thompson and Dylan Desjardins on distributional language in executive orders and a new report by the OECD on agile regulation.

There are also events with Center scholars hosted by the Library of Congress, U.S. House Select Committee on the Modernization of Congress, American Political Science Assocation, Southern Economic Association, American Enterprise Institute, and the Regulatory Transparency Project.

Previous Editions

FULL NEWSLETTER

This update features a recent report by co-authored by Steve Balla and Bridget Dooling Mass, Computer-Generated, and Fraudulent Comments, for the Administrative Conference of the United States.  Dooling and Balla also joined Susan Dudley on the GW Trachtenberg School's summer conversation series to discuss the report and more: Mass, Bots, and Fake Comments on Rulemaking.

The update also includes research by Tara Sinclair and Zhoudan Xie on Sentiment and Uncertainty about Regulation, Mark Febrizio and Kekai Liu on The Frequency of Regulatory Suspensions in the 21st Century, commentary on President Biden's executive order on competition, distributional effects in regulatory impact analysis, equity in rulemaking, agency guidance documents, and antitrust enforcement..

Also featured is Bridget Dooling's selection by the Administrative Conference of the United States to work with Rachel Potter from the University of Virginia to study the use of contractors in the rulemaking process.

Plus various op-eds in Slate and Forbes, events with the Regulatory Transparency Project, Case Western University, Women in Government Relations, Environmental Protection Agency, and the ABA's AdLaw Section. Plus quotes in popular media outlets, including the Los Angeles Times, The Hill, and Yahoo.

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Unsupervised Use of Opioid Treatment Medications, which is the second part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes a Congressional testimony by Howard Beales, and analysis of the Congressional Review Act by Daniel Pérez, President Biden's actions to undo Trump administration rulemaking by Mark Febrizio, and a report to the Administrative Conference of the United States by Steve Balla and Bridget Dooling.

Also featured is Bridget Dooling's appearance on the GovActually podcast with Princeton University professor Martha Coven to discuss being a part of the Biden Transition Team.

Plus various op-eds in the The Philadelphia Inquirer and Forbes, events with ABA AdLaw Section, Society for Benefit-Cost Analysis, Environmental Law Institute, Midwest Political Science Assocation, and the GW Economics Department, and quotes in popular media outlets, including The Wall Street JournalNPR, Government Executive, Daily Beast, Marketplace, and Axios.

FULL NEWSLETTER

This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project.  It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.

There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.

Plus various op-eds in the Wall Street Journal, The Hill, Forbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street JournalFederal News Network, Science, Bloomberg, USA Today, and Axios.

FULL NEWSLETTER

This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.

There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street JournalNew York Times, The Hill, Bloomberg, Forbes, PoliticoReutersAudubon MagazineGovernment Executive, and Law360.

FULL NEWSLETTER

This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.

There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.